The challenges and future directions for the clinical implementation of the KD in the treatment of a spectrum of diseases have been discussed
Original Articles Basic and Translational Research LRRFIP1 Inhibits White Adipocyte Differentiation by Suppressing the E2F6/C/EBP Axis Lei Zhou, Yuwen Jiao, Jiaming Xue, Xiaoqiang Zhan, Dongmei Wang, Liming Tang Received March 4, 2025 Accepted July 24, 2025 Published online November 12, 2025 DOI: [Epub ahead of print] 1,822 View 62 Download 2 Crossref Abstract PDFSupplementary MaterialPubReader ePub Background To investigate the biological functions of the transcription factor LRR binding FLII interacting protein 1 (LRRFIP1) in white adipocyte differentiation (WAD) and elucidate the underlying molecular regulatory mechanisms involved
Experimental approaches, such as miR-34a modulation, 17-estradiol supplementation, and L-carnitine administration, show promise in mitigating ketamine-induced neurotoxicity (Li et al., 2013
The interplay between sleep and gut microbiota
Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice
It supports blood vessel dilation, which may have a positive impact on blood pressure, exercise performance, and sexual function